During the past decade, Schüchtermann-Klinik conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schüchtermann-Klinik" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Edwards Lifesciences" with 3 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored, "Institut für Klinisch-Kardiovaskuläre Forschung GmbH" with 1 trials sponsored and "Institut für Pharmakologie und Präventive Medizin" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schüchtermann-Klinik" #1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Schüchtermann-Klinik" are "Aortic Valve Stenosis" (3 trials), "Aortic Valve Insufficiency" (1 trials), "Biventricular Pacemakers, Artificial" (1 trials), "Cardiac Resynchronization" (1 trials) and "Cardiac Resynchronization Therapy" (1 trials). Many other conditions were trialed in "Schüchtermann-Klinik" in a lesser frequency.

Most popular intervention types in "Schüchtermann-Klinik" are "Device" (10 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "HARPOON Beating Heart Mitral Valve Repair System (MVRS)" (2 trials), "(ALLEGRA Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis" (1 trials), "BAV" (1 trials), "CRT-D device replacement" (1 trials) and "HeartWare Ventricular Assist Device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schüchtermann-Klinik" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Schüchtermann-Klinik". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Schüchtermann-Klinik, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Schüchtermann-Klinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".